Cross promotion - LOL. It's a science paper and NOT a listed company to the sad zealot that TOUed that, you are pathetic.
"Exosomes have raised high hopes in biomedicine for more than 20 years now. With this new technology in hands, we are now able to synthetize exosomes with high purity on a therapeutic scale. This overcomes some of the major limitations that have impeded the application of exosomes for therapy and could lead us to harness the power of extracellular vesicle communication. Moreover, as we are working with very defined vesicle systems, we are now able to study the fundamental functions of EV in a very systematic way."
Reference: Staufer O, Dietrich F, Rimal R, et al. Bottom-up assembly of biomedical relevant fully synthetic extracellular vesicles. Sci Adv. 2021;7(36). doi: 10.1126/sciadv.abg6666
EX1 Price at posting:
49.5¢ Sentiment: Buy Disclosure: Not Held
